Early prenatal biochemical screening, present state, current problems and options

Cover Page


Cite item

Full Text

Abstract

In Saint-Petersburg total biochemical screening for Down’s syndrome in 2-d trimester have been established since 1997. Also all pregnant women underwent ultrasound examinations for screening for chromosomal abnormalities. Results of introduction of 1-st trimester combined screening since 2006, its influence for detection rate, achievements and problems were discussed in our paper

About the authors

Tat'yana Konstantinovna Kascheeva

D. O. Ott Research Institute of Obstetrics and Gynecology, Northwest Branch of the Russian Academy of Medical Sciences

Email: tkklpd@mail.ru
leading researcher, Doct. Biol. Sci

Yukiya Anatolevna Nikolaeva

D. O. Ott Research Institute of Obstetrics and Gynecology, Northwest Branch of the Russian Academy of Medical Sciences

OB/GYN doctor

Vladislav Sergeevich Baranov

D. O. Ott Research Institute of Obstetrics and Gynecology, Northwest Branch of the Russian Academy of Medical Sciences

Email: iagmail@ott.ru
professor, chief of the Laboratory for Prenatal Diagnosis

Konstantin Romanovich Karpov

City Medical Genetic Center

Deputy Head of the Clinic, PhD

Nataliya Vasilevna Vokhmyanina

City Medical Genetic Center

chief of biochemical laboratory, Ph.D

Olga Panteleymonovna Romanenko

City Medical Genetic Center

Head of the Clinic, Doct.Med.Sci

References

  1. Внедрение алгоритма комбинированного скрининга хромосомной патологии плода в 1 триместре беременности. Опыт работы за 4 года / Некрасова Е. С. [и др.] // Журнал акушерства женских болезней. — 2007. — № 1. — С. 28–34.
  2. Итоги массового биохимического скрининга беременных в Санкт-Петербурге (2008–2009) / Кащеева Т. К. [и др.] // Молекулярно-биологические технологии в медицинской практике. Вып. 14 / ред. А. Б. Масленников. — Новосибирск, 2010. — С. 160–165.
  3. Николаидес К. Ультразвуковое исследование в 11–13 недель беременности. — СПб.: Петрополис, 2007. — 144 с.
  4. Cовременные алгоритмы пренатальной диагностики наследственных болезней: метод. пособие / Баранов В. С. [и др.]. — СПб.: Изд-во Н-Л, 2009. — 130 с.
  5. Cuckle H. S. Monitoring quality control of nuchal translucency // Clin. Lab. Med. — 2010. — Vol. 30. — P. 593–604.
  6. Danish Fetal Medicine Reseach Group. Impact of new national screening policy for Down’s screening in Denmark: population based cohort study / Ekelund C. K. [et al.] // Br. Med. J. — 2008. — Vol.337. — a2547.
  7. Evans M. I., Van Decruyes H., Nikolaides K. H. Nuchal translucency measurements for first trimester screening: the “price” of inaccuracy // Fetal Diag. Ther. — 2007. — Vol. 22. — P. 401–404.
  8. First trimester combined screening for trisomy 21 at 8–13 weeks / Wright D. [et al.] // Ultrasound Obstet. Gynecol. — 2010. — Vol. 36. — P. 404–411.
  9. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A / Kagan K. O. [et al.] // Ultrasound Obstet. Gynecol. — 2008. — Vol. 31. — P. 619–624

Copyright (c) 2012 Kascheeva T.K., Nikolaeva Y.A., Baranov V.S., Karpov K.R., Vokhmyanina N.V., Romanenko O.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies